指南与共识瓣膜病与结构性心脏病

2020 ACC/AHA 瓣膜性心脏病管理指南执行摘要

2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
指南 / 共识 · Circulation · 2020-12-17

该执行摘要基于2010年1月至2020年3月的综合文献检索,更新了瓣膜性心脏病的诊断与治疗推荐,涵盖诊断检查、手术与导管干预的时机与选择以及药物治疗,并附支持性文档以促进指南应用。

要点

  • 更新了瓣膜性心脏病的诊断与治疗推荐,纳入新证据。
  • 重点涵盖诊断检查、手术与导管干预时机与选择、药物治疗。
  • 执行摘要仅包含完整指南中的推荐条款,细节需参考完整指南。

核心结论

  • 该执行摘要为临床医生诊断和管理瓣膜性心脏病提供推荐,并附支持性文档以鼓励应用。

研究设计与样本

  • 制定机构为美国心脏病学会(ACC)与美国心脏协会(AHA)联合委员会临床实践指南;方法为综合文献检索,检索时间为2010年1月1日至2020年3月1日,涵盖英文发表的人体研究、综述及其他证据,来源包括PubMed、EMBASE、Cochrane、Agency for Healthcare Research and Quality Reports及其他相关数据库。

主要发现

  • 早期瓣膜性心脏病指南的许多推荐已根据新证据更新,并为诊断和治疗提供了更新选择。

关键数值与推荐

  • 执行摘要仅包含完整指南中聚焦诊断检查、手术与导管干预的时机和选择以及药物治疗的推荐条款。

临床怎么用

  • 临床医生可依据该执行摘要中的推荐进行瓣膜性心脏病的诊断、干预时机与方式选择及药物治疗。

局限性

  • 执行摘要不包含完整指南中的流程图、正文、表格、推荐理由与实施细节以及证据表,读者需参考完整指南。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: This executive summary of the valvular heart disease guideline provides recommendations for clinicians to diagnose and manage valvular heart disease as well as supporting documentation to encourage their use. METHODS: A comprehensive literature search was conducted from January 1, 2010, to March 1, 2020, encompassing studies, reviews, and other evidence conducted on human subjects that were published in English from PubMed, EMBASE, Cochrane, Agency for Healthcare Research and Quality Reports, and other selected database relevant to this guideline. Structure: Many recommendations from the earlier valvular heart disease guidelines have been updated with new evidence and provides newer options for diagnosis and treatment of valvular heart disease. This summary includes only the recommendations from the full guideline which focus on diagnostic work-up, the timing and choice of surgical and catheter interventions, and recommendations for medical therapy. The reader is referred to the full guideline for graphical flow charts, text, and tables with additional details about the rationale for and implementation of each recommendation, and the evidence tables detailing the data considered in developing these guidelines.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2020. PMID: 33332149. doi:10.1161/CIR.0000000000000932

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。